Experience

Faculty of Pharmacy of the University of Lisbon
• Portugal
• Higher Education
• 1 - 100 Employee
• Full Professor

  • Jan 2020 - Present


iMed - The Research Institute for Medicines

• Group Leader and Principal Investigator

  • Jan 2010 - Present

  We embrace the theme RESEARCH Develops MEDICINES, emphasizing the impact that high quality research has on effective development of novel therapeutics, thus benefiting human health and society wellbeing. Strategic Priority 1: Create innovative scientific solutions Supporting research from basic to translational that is most likely to develop medicines, focusing on four Program Areas of Drug Discovery, Drug Design, Drug Development, and Drug Usage Strategic Priority 2: Bridge… Show more We embrace the theme RESEARCH Develops MEDICINES, emphasizing the impact that high quality research has on effective development of novel therapeutics, thus benefiting human health and society wellbeing. Strategic Priority 1: Create innovative scientific solutions Supporting research from basic to translational that is most likely to develop medicines, focusing on four Program Areas of Drug Discovery, Drug Design, Drug Development, and Drug Usage Strategic Priority 2: Bridge research and society Expanding networks and synergies to ensure recognition of iMed.ULisboa value and contributions, and return the impact of fundamental research to people Strategic Priority 3: Enable scientists and train students Sustaining a robust and flourishing environment for world-class medicines research and training Strategic Priority 4: Optimize organizational effectiveness Building on existing organizational strengths, considering and pursuing opportunities for improvement Show less We embrace the theme RESEARCH Develops MEDICINES, emphasizing the impact that high quality research has on effective development of novel therapeutics, thus benefiting human health and society wellbeing. Strategic Priority 1: Create innovative scientific solutions Supporting research from basic to translational that is most likely to develop medicines, focusing on four Program Areas of Drug Discovery, Drug Design, Drug Development, and Drug Usage Strategic Priority 2: Bridge… Show more We embrace the theme RESEARCH Develops MEDICINES, emphasizing the impact that high quality research has on effective development of novel therapeutics, thus benefiting human health and society wellbeing. Strategic Priority 1: Create innovative scientific solutions Supporting research from basic to translational that is most likely to develop medicines, focusing on four Program Areas of Drug Discovery, Drug Design, Drug Development, and Drug Usage Strategic Priority 2: Bridge research and society Expanding networks and synergies to ensure recognition of iMed.ULisboa value and contributions, and return the impact of fundamental research to people Strategic Priority 3: Enable scientists and train students Sustaining a robust and flourishing environment for world-class medicines research and training Strategic Priority 4: Optimize organizational effectiveness Building on existing organizational strengths, considering and pursuing opportunities for improvement Show less



Faculdade de Farmácia Universidade de Lisboa

• Tenured Associate Professor

  • Jul 2013 - Jan 2020

  With Habilitation and Tenured With Habilitation and Tenured


Faculdade farmácia Universidade Lisboa
• Associate Professor

  • Jun 2006 - Jun 2013

Faculdade de Farmácia Universidade Lisboa
• Assistant Professor

  • Feb 2001 - May 2006

The Scripps Research Institute
• Research Fellow

  • Jan 1999 - Dec 2000

Merck Sharp & Dohme
• United Kingdom
• Product Manager

  • Jan 1997 - Dec 1998

Servier
• France
• Pharmaceutical Manufacturing
• 700 & Above Employee
• Product Manager

  • Sep 1995 - Dec 1996

Dana-Farber Cancer Institute
• United States
• Hospitals and Health Care
• 700 & Above Employee
• Research Fellow

  • Jan 1990 - Aug 1995